WuXi XDC Reports 90.8% Revenue Surge, Expanding in ADC Market
Company

WuXi XDC Reports 90.8% Revenue Surge, Expanding in ADC Market

Suzhou Xueji Biotech's XJ-MK-002 Gets FDA Orphan Drug Designation for CAMT
CompanyDrug

Suzhou Xueji Biotech’s XJ-MK-002 Gets FDA Orphan Drug Designation for CAMT

Beijing Sungen Biomedical's SGC001 Receives FDA Fast Track Designation for AMI Treatment
CompanyDrug

Beijing Sungen Biomedical’s SGC001 Receives FDA Fast Track Designation for AMI Treatment

CanSino Biologics Partners with Grand Life Sciences to Commercialize Tetanus Vaccine in Greater China
CompanyDeals

CanSino Biologics Partners with Grand Life Sciences to Commercialize Tetanus Vaccine in Greater China

AllianThera Biopharma Starts Global Phase I Trial for ATB102 in Inflammatory Bowel Diseases
CompanyDrug

AllianThera Biopharma Starts Global Phase I Trial for ATB102 in Inflammatory Bowel Diseases

Jiangsu Hengrui Pharmaceuticals' Ivarmacitinib Receives NMPA Approval for Ankylosing Spondylitis
CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Ivarmacitinib Receives NMPA Approval for Ankylosing Spondylitis

Oriomics' Liver Cancer Screening Reagent Earns FDA Breakthrough Device Designation
CompanyMedical Device

Oriomics’ Liver Cancer Screening Reagent Earns FDA Breakthrough Device Designation

Kexing Biopharm Partners with BioMap on AI-Driven Macromolecular Drug Development
CompanyDeals

Kexing Biopharm Partners with BioMap on AI-Driven Macromolecular Drug Development

CStone Pharmaceuticals Files for EMA Approval of Sugemalimab for Unresectable Stage III NSCLC
CompanyDrug

CStone Pharmaceuticals Files for EMA Approval of Sugemalimab for Unresectable Stage III NSCLC

Abbisko Therapeutics and Allist Pharmaceuticals Partner on KRAS-G12C NSCLC Combination Therapy
CompanyDeals

Abbisko Therapeutics and Allist Pharmaceuticals Partner on KRAS-G12C NSCLC Combination Therapy

Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation
Company

Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation

Clover Biopharmaceuticals Receives FDA Approval for SCB-1019 RSV Vaccine Trial
CompanyDrug

Clover Biopharmaceuticals Receives FDA Approval for SCB-1019 RSV Vaccine Trial